Knoll Capital Management, LLC 13F 持仓 · 2026年Q2
Knoll Capital Management 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 37 只证券，申报市值合计 2.14 亿美元。前几大持仓：BHVN1（16.33%）、MGTX（7.88%）、PHYS（5.45%）。本季前 25 大持仓中：新建仓 1 只、增持 4 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | BHVN1 | Biohaven Pharmactl Hldg Co | $35.0M | 16.33% | 2.4M | 增持 |
| 2 | MGTX | MeiraGTX Holdings | $16.9M | 7.88% | 1.2M | 持平 |
| 3 | PHYS | Sprott physical gold Trust | $11.7M | 5.45% | 387,055 | 持平 |
| 4 | ALDX | Aldeyra Therapeutics Inc | $11.7M | 5.44% | 5.5M | 持平 |
| 5 | OCUL | Ocular Therapeutix Inc. | $11.3M | 5.27% | 1.2M | 增持 |
| 6 | RGLD | Royal Gold Inc. | $10.5M | 4.91% | 52,750 | 持平 |
| 7 | ENTX | Entera Bio Ltd | $10.4M | 4.86% | 5.9M | 持平 |
| 8 | NUVB | Nuvation Bio Inc | $9.1M | 4.24% | 1.6M | 增持 |
| 9 | AEM | Agnico Eagle Mines Ltd | $8.2M | 3.82% | 52,750 | 持平 |
| 10 | SA | SEABRIDGE GOLD INC | $8.2M | 3.81% | 317,003 | 持平 |
| 11 | KGC | Kinross Gold Corp | $7.6M | 3.53% | 320,000 | 持平 |
| 12 | OR | OR Royalties | $7.1M | 3.32% | 225,000 | 持平 |
| 13 | SSRM | SSR Mining In | $6.9M | 3.23% | 245,000 | 持平 |
| 14 | FNV | Franco Nev Corp | $6.7M | 3.11% | 32,000 | 持平 |
| 15 | BAH | Booz Allen Hamilton HLDG COR | $5.7M | 2.66% | 13,000 | 持平 |
| 16 | CGAU | Centerra Gold Inc | $5.7M | 2.66% | 359,000 | 持平 |
| 17 | ELTX | Elicio Therapeutics Inc | $4.7M | 2.21% | 1.2M | 增持 |
| 18 | ABVX | Abivax SA Spons | $4.7M | 2.18% | 35,000 | 新建仓 |
| 19 | PAAS | Pan American Silver | $4.5M | 2.09% | 100,035 | 持平 |
| 20 | PSLV | Sprott Physical silver Trust | $4.2M | 1.96% | 222,160 | 持平 |
| 21 | TFPM | Triple Flag Precious Metals | $3.4M | 1.61% | 115,000 | 持平 |
| 22 | ABEO | Abeona Therapeutics | $3.0M | 1.40% | 485,515 | 持平 |
| 23 | GROY | Gold RTY Corp | $2.8M | 1.29% | 1.0M | 持平 |
| 24 | NEWP | New Pac Metals Corp | $1.9M | 0.91% | 485,000 | 持平 |
| 25 | ITA | iSHares US Aerospace & Defense | $1.9M | 0.87% | 7,650 | 持平 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR